iSpecimen Inc. (ISPC)
NASDAQ: ISPC · Real-Time Price · USD
0.8246
+0.0135 (1.66%)
At close: Aug 22, 2025, 4:00 PM
0.8000
-0.0246 (-2.98%)
After-hours: Aug 22, 2025, 7:59 PM EDT
iSpecimen Market Cap
iSpecimen has a market cap or net worth of $4.57 million as of August 22, 2025. Its market cap has increased by 39.50% in one year.
Market Cap
4.57M
Enterprise Value
4.27M
1-Year Change
39.50%
Ranking
Category
Stock Price
$0.82
Market Cap Chart
Since the IPO on June 17, 2021, iSpecimen's market cap has decreased from $50.15M to $4.57M, a decrease of -90.89%. That is a compound annual growth rate of -43.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 4.57M | 78.72% |
| Dec 31, 2024 | 2.56M | -43.75% |
| Dec 29, 2023 | 4.54M | -62.95% |
| Dec 30, 2022 | 12.26M | -81.98% |
| Dec 31, 2021 | 68.07M | 35.75% |
| Jun 17, 2021 | 50.15M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 633.30B |
| Johnson & Johnson | 430.71B |
| AbbVie | 369.48B |
| UnitedHealth Group | 271.56B |
| AstraZeneca | 250.11B |
| Novartis AG | 246.48B |
| Novo Nordisk | 239.90B |
| Abbott Laboratories | 230.51B |